Lotus Herbals Backs KorinMi with ₹10 Crore Investment for Pan-India Expansion

This ₹10 crore injection marks the startup’s second major funding milestone. In May last year, KorinMi raised ₹3 crore in an angel round from Vikas Agarwal, the former CEO of Kaya Skin Clinic (UAE), a

Gurugram-based skin clinic startup KorinMi has secured a fresh ₹10 crore investment from Lotus Herbals’ Innovation Fund to accelerate a pan-India expansion of its clinic network and services. The infusion — part of Lotus Herbals’ $50 million venture fund that backs early-stage beauty and wellness startups in India — will help KorinMi scale its physical footprint to major metros, including Mumbai, Bengaluru and Hyderabad, and deepen its hybrid clinic-plus-D2C model. This is the startup’s second major funding milestone after a ₹3 crore angel round in May last year led by Vikas Agarwal, the former CEO of Kaya Skin Clinic (UAE), alongside other private investors.

"Our treatments focus on both facial and hair care, utilizing equipment and clinical products sourced directly from South Korea," the company stated in a press release.

Context and details

KorinMi was co-founded in 2024 by Reshbha Munjal and Jenovia Daun Jung with the stated goal of bridging Korean skin science and customized clinical treatments calibrated for Indian skin. The startup opened its flagship clinic in Gurugram in October 2024 and has served more than 3,000 clients since launch, according to the company. Typical treatment cycles run 30–45 days.

  • Investor and fund: The ₹10 crore comes from Lotus Herbals’ Innovation Fund, which is part of the parent company’s $50 million venture fund focused on early-stage beauty and wellness plays in India.
  • Lotus Herbals’ prior moves: The investment follows Lotus Herbals’ earlier portfolio diversification, including a 32% stake acquisition in skincare brand Fixderma in October 2021.
  • Previous funding: In May 2025 KorinMi raised ₹3 crore in an angel round from Vikas Agarwal and other private backers.
  • Product strategy: Beyond in-clinic services, KorinMi has launched a direct-to-consumer skincare line that is manufactured in South Korea but formulated to withstand Indian weather conditions and address local skin types.
  • Service model: The startup operates a hybrid model combining tech-backed physical clinics with a D2C product business; clinical equipment and products are sourced directly from South Korea.

Outlook

With Lotus Herbals’ ₹10 crore backing, KorinMi plans to establish new advanced clinics in Mumbai, Bengaluru and Hyderabad as it moves from a single flagship location toward a broader national presence. The capital is earmarked to accelerate geographic expansion and scale the company’s hybrid clinical and product offerings. For Lotus Herbals, the investment deepens its play in early-stage beauty and wellness startups and continues a multiyear strategy of acquiring stakes in specialist skincare brands.